Chemours (CC) Misses Q1 EPS by 10c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Wall St futures pause after AI rally, focus on Mideast tensions
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Chemours (CC) PT Lowered to $11.50 at Jefferies
May 8, 2025 12:55 PM EDTJefferies analyst Laurence Alexander lowered the price target on Chemours (NYSE: CC) to $11.50 (from $20.00) while maintaining a Hold rating.
The analyst comments "Q1 EPS of $0.13 was $0.07 below consensus and $0.21 below our estimate. Supply chain distortions appear to be a near-term headwind, while a... More
